Self-reported risk of stroke and factors associated with underestimation of stroke risk among older adults with atrial fibrillation: the SAGE-AF study

被引:4
作者
Mehawej, Jordy [1 ]
Saczynski, Jane [2 ]
Gurwitz, Jerry H. [3 ,4 ,5 ]
Abu, Hawa O. [1 ]
Bamgbade, Benita A. [2 ]
Wang, Wei-Jia [1 ]
Paul, Tenes [1 ]
Trymbulak, Katherine [1 ]
Saleeba, Connor [1 ]
Wang, Zi-Yue [1 ]
Kiefe, Catarina, I [3 ]
Goldberg, Robert J. [3 ]
McManus, David D. [1 ]
机构
[1] Univ Massachusetts, Dept Med, Med Sch, Div Cardiovasc Med, Worcester, MA 01655 USA
[2] Northeastern Univ, Sch Pharm, Dept Pharm & Hlth Syst Sci, Boston, MA 02115 USA
[3] Univ Massachusetts, Dept Populat & Quantitat Hlth Sci, Med Sch, Worcester, MA 01605 USA
[4] Univ Massachusetts, Med Sch, Div Geriatr Med, Worcester, MA 01605 USA
[5] Univ Massachusetts, Med Sch, Meyers Primary Care Inst, Worcester, MA 01605 USA
关键词
Anticoagulation; Atrial fibrillation; Stroke; SHARED DECISION-MAKING; STRATIFICATION; ANTICOAGULATION; GUIDELINES; MANAGEMENT; PHYSICIAN; EFFICACY; CHADS(2); BARRIERS;
D O I
10.11909/j.issn.1671-5411.2020.08.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Though engaging patients with atrial fibrillation (AF) in understanding their stroke risk is encouraged by guidelines, little is known regarding AF patients' perceived stroke risk or its relationship with oral anticoagulation (OAC) use. We aim to identify factors associated with underestimation of stroke risk among older patients with AF and relate this to OAC use. Methods Data are from the ongoing SAGE (Systematic Assessment of Geriatric Elements)-AF study, which included older patients (> 65 years) with non-valvular AF and a CHA(2)DS(2)-VASc score of >= 2. Participants reported their perceived risk of having a stroke without OAC. We compared the perceived risk to CHA(2)DS(2)-VASc predicted stroke risk and classified participants as "over" or "under" estimators, and identified factors associated with underestimation of risk using multiple logistic regression. Results The average CHA(2)DS(2)-VASc score of 915 participants (average age: 75 years, 47% female, 86% white) was 4.3 +/- 1.6, 43% of participants had discordant predicted and self-reported stroke risks. Among the 376 participants at highest risk (CHA(2)DS(2)-VASc score >= 5), 46% of participants underestimated their risk. Older participants (>= 85 years) were more likely and OAC treated patients less likely to underestimate their risk of developing a future stroke than respective comparison groups. Conclusions A significant proportion of study participants misperceived their stroke risk, mostly by overestimating. Almost half of participants at high risk of stroke underestimated their risk, with older patients more likely to do so. Patients on OAC were less likely to underestimate their risk, suggesting that successful efforts to educate patients about their stroke risk may influence treatment choices.
引用
收藏
页码:502 / 509
页数:8
相关论文
共 33 条
[1]   An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality [J].
Aliot, Etienne ;
Breithardt, Guenter ;
Brugada, Josep ;
Camm, John ;
Lip, Gregory Y. H. ;
Vardas, Panos E. ;
Wagner, Markus .
EUROPACE, 2010, 12 (05) :626-633
[2]   The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients [J].
Cano, Stefan J. ;
Lamping, Donna L. ;
Bamber, Luke ;
Smith, Sarah .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2012, 10
[3]   Atrial fibrillation and risk of stroke: a nationwide cohort study [J].
Christiansen, Christine Benn ;
Gerds, Thomas A. ;
Olesen, Jonas Bjerring ;
Kristensen, Soren Lund ;
Lamberts, Morten ;
Lip, Gregory Y. H. ;
Gislason, Gunnar H. ;
Kober, Lars ;
Torp-Pedersen, Christian .
EUROPACE, 2016, 18 (11) :1689-1697
[4]   Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study [J].
Chugh, Sumeet S. ;
Havmoeller, Rasmus ;
Narayanan, Kumar ;
Singh, David ;
Rienstra, Michiel ;
Benjamin, Emelia J. ;
Gillum, Richard F. ;
Kim, Young-Hoon ;
McAnulty, John H. ;
Zheng, Zhi-Jie ;
Forouzanfar, Mohammad H. ;
Naghavi, Mohsen ;
Mensah, George A. ;
Ezzati, Majid ;
Murray, Christopher J. L. .
CIRCULATION, 2014, 129 (08) :837-847
[5]   Shared decision-making tool for thromboprophylaxis in atrial fibrillation - A feasibility study [J].
Eckman, Mark H. ;
Costea, Alexandru ;
Attari, Mehran ;
Munjal, Jitender ;
Wise, Ruth E. ;
Knochelmann, Carol ;
Flaherty, Matthew L. ;
Baker, Pete ;
Ireton, Robert ;
Harnett, Brett M. ;
Leonard, Anthony C. ;
Steen, Dylan ;
Rose, Adam ;
Kues, John .
AMERICAN HEART JOURNAL, 2018, 199 :13-21
[6]   Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study [J].
Friberg, Leif ;
Rosenqvist, Marten ;
Lip, Gregory Y. H. .
EUROPEAN HEART JOURNAL, 2012, 33 (12) :1500-+
[7]   Barriers to the use of anticoagulation for nonvalvular atrial fibrillation - A representative survey of Australian family physicians [J].
Gattellari, Melina ;
Worthington, John ;
Zwar, Nicholas ;
Middleton, Sandy .
STROKE, 2008, 39 (01) :227-230
[8]   Perception of the Risk of Stroke and the Risks and Benefits of Oral Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation: A Cross-Sectional Study [J].
Hijazi, Mohammad ;
Aljohani, Sami ;
Alqahtani, Fahad ;
Chaker, Zakeih ;
Al Hajji, Muhammad ;
Al Hallak, Ahmad ;
Alkhouli, Mohamad .
MAYO CLINIC PROCEEDINGS, 2019, 94 (06) :1015-1023
[9]  
Holm A.L., 2016, OPEN J NURSING, V6, P170, DOI [DOI 10.4236/OJN.2016.63018, 10.4236/ojn.2016]
[10]   What are the barriers to warfarin use in atrial fibrillation?:: Development of a questionnaire [J].
Ingelgård, A ;
Hollowell, J ;
Reddy, P ;
Gold, K ;
Tran, K ;
Fitzmaurice, D .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2006, 21 (03) :257-265